NM_014865.4:c.3801A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_014865.4(NCAPD2):c.3801A>G(p.Val1267Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.727 in 1,613,992 control chromosomes in the GnomAD database, including 428,983 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.77 ( 45947 hom., cov: 34)
Exomes 𝑓: 0.72 ( 383036 hom. )
Consequence
NCAPD2
NM_014865.4 synonymous
NM_014865.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.700
Publications
26 publications found
Genes affected
NCAPD2 (HGNC:24305): (non-SMC condensin I complex subunit D2) Enables histone binding activity. Involved in mitotic chromosome condensation. Located in condensed chromosome; cytosol; and nucleoplasm. Part of condensin complex. Colocalizes with cytoplasm and nuclear chromosome. Implicated in primary autosomal recessive microcephaly. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 12-6529922-A-G is Benign according to our data. Variant chr12-6529922-A-G is described in ClinVar as Benign. ClinVar VariationId is 1321849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.7 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.891 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.772 AC: 117493AN: 152098Hom.: 45896 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
117493
AN:
152098
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.744 AC: 186921AN: 251378 AF XY: 0.733 show subpopulations
GnomAD2 exomes
AF:
AC:
186921
AN:
251378
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.723 AC: 1056491AN: 1461776Hom.: 383036 Cov.: 65 AF XY: 0.720 AC XY: 523942AN XY: 727202 show subpopulations
GnomAD4 exome
AF:
AC:
1056491
AN:
1461776
Hom.:
Cov.:
65
AF XY:
AC XY:
523942
AN XY:
727202
show subpopulations
African (AFR)
AF:
AC:
30360
AN:
33478
American (AMR)
AF:
AC:
38208
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
AC:
18488
AN:
26126
East Asian (EAS)
AF:
AC:
27217
AN:
39698
South Asian (SAS)
AF:
AC:
58884
AN:
86246
European-Finnish (FIN)
AF:
AC:
40288
AN:
53416
Middle Eastern (MID)
AF:
AC:
3986
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
795136
AN:
1111942
Other (OTH)
AF:
AC:
43924
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
16930
33860
50791
67721
84651
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
19962
39924
59886
79848
99810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.773 AC: 117606AN: 152216Hom.: 45947 Cov.: 34 AF XY: 0.772 AC XY: 57471AN XY: 74410 show subpopulations
GnomAD4 genome
AF:
AC:
117606
AN:
152216
Hom.:
Cov.:
34
AF XY:
AC XY:
57471
AN XY:
74410
show subpopulations
African (AFR)
AF:
AC:
37341
AN:
41564
American (AMR)
AF:
AC:
12096
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
2474
AN:
3472
East Asian (EAS)
AF:
AC:
3594
AN:
5160
South Asian (SAS)
AF:
AC:
3247
AN:
4820
European-Finnish (FIN)
AF:
AC:
8000
AN:
10586
Middle Eastern (MID)
AF:
AC:
199
AN:
294
European-Non Finnish (NFE)
AF:
AC:
48515
AN:
67996
Other (OTH)
AF:
AC:
1581
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1378
2756
4134
5512
6890
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
858
1716
2574
3432
4290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2665
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Microcephaly 21, primary, autosomal recessive Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.